Quick Takeaways
- Deep Track Capital, LP filed SCHEDULE 13G for Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA).
- Disclosed ownership: 5.1%.
- Date of event: 06 May 2025.
Deep Track Capital, LP - 06 May 2025 SCHEDULE 13G Report for Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA)
- Filing Manager
- Deep Track Capital, LP
- Reporting Manager
- Deep Track Capital, LP
- Symbol
- ORKA
- Shares outstanding
- 37,411,834 shares
- Disclosed Ownership
- 1,896,780 shares
- Ownership
- 5.1%
- Form type
- SCHEDULE 13G
- Filing time
- 13 May 2025, 16:32:07 UTC
- Date of event
- 06 May 2025
- Next filing
- 13 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Deep Track Capital, LP disclosed 5.1% ownership in Oruka Therapeutics, Inc. Common Stock, par value $0.001 per share (ORKA) on 06 May 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 13 May 2025, 16:32.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deep Track Capital, LP | 5.1% | 1,896,780 | 0 | 1,896,780 | /s/ David Kroin | David Kroin, Managing Member of the General Partner of the Investment Adviser | |
| Deep Track Biotechnology Master Fund, Ltd. | 5.1% | 1,896,780 | 0 | 1,896,780 | /s/ David Kroin | David Kroin, Director | |
| David Kroin | 5.1% | 1,896,780 | 0 | 1,896,780 | /s/ David Kroin | David Kroin |